Survey details ongoing shortage of cancer medications
A survey released Sept. 10 by the National Comprehensive Cancer Network highlights ongoing shortages of cancer medications. All responding cancer centers reported a shortage of at least one anti-cancer agent, with more than 20% currently experiencing a shortage of five or more medications. Of particular note, 94% of respondents indicated a critical shortage of ifosfamide — a generic drug used to treat a variety of cancers — and 71% reported a shortage of the cancer-treating drug carboplatin.
Related News Articles
Headline
In this conversation, Kardie Tobb, D.O., a non-invasive preventative cardiologist at Cone Health, explains how multidisciplinary teams are breaking down…
Headline
The Common Health Coalition announced Aug. 13 that it will receive $100 million in funding from the OpenAI Foundation for a new initiative using artificial…
Headline
The Department of Health and Human Services July 22 announced that it will participate in the Genesis Mission, an artificial intelligence initiative focusing…
Headline
The Food and Drug Administration July 10 released a proposed rule that would modernize drug establishment registration requirements, with implications for…
Headline
Ryane Jackson, vice president of Community Health Network at Memorial Hermann Health System, explains how the system is creating seamless connections between…
Headline
The American Cancer Society released updated colorectal cancer screening guidelines May 27 that include the addition of a blood-based screening test to be…